Corbion Q1 2014 Interim Management Statement

Corbion reported positive net sales and EBITDA growth in Q1 2014 despite significant negative exchange rate effects. Organic sales growth was 3.0% due to strong growth in the Biochemicals segment. EBITDA before one-off costs at constant currencies increased by � 3.2 million or 13.6% compared to Q1 2013. Expenditure on R&D rose significantly.

View all Corbion Press releases




  1. Please tell us your name

  2. Please tell us which company you work for

  3. Please provide your email address

    Please enter a valid email address

  4. Please tell us the country you work in

  5. Please inform us about your area of interest

  6. Please tell us what you are looking for or how we can help you.

  7. Please tell us how you heard about us

  8. Please type in the numbers to verify you are a real person

    Please verify that the numbers you entered are correct.